Advanced Search
Contact | Corporate | Help

Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer

Sponsors:
  • Washington University School of Medicine
  • GlaxoSmithKline
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Cervical Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Female
Names:
  • Drug: Topotecan + Cisplatin + Bevacizumab
Enrollment:
30

Additional information about NCT00548418.


SourceSolution © 2008-2012